440 Investment Group LLC reduced its stake in Agilent Technologies, Inc. (NYSE:A) by 10.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,231 shares of the medical research company’s stock after selling 700 shares during the period. 440 Investment Group LLC’s holdings in Agilent Technologies were worth $370,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the company. CENTRAL TRUST Co increased its stake in Agilent Technologies by 15.3% in the first quarter. CENTRAL TRUST Co now owns 2,994 shares of the medical research company’s stock valued at $158,000 after buying an additional 398 shares in the last quarter. Creative Planning increased its stake in Agilent Technologies by 6.3% in the first quarter. Creative Planning now owns 11,961 shares of the medical research company’s stock valued at $632,000 after buying an additional 710 shares in the last quarter. Gulf International Bank UK Ltd increased its stake in Agilent Technologies by 3.7% in the first quarter. Gulf International Bank UK Ltd now owns 101,706 shares of the medical research company’s stock valued at $5,377,000 after buying an additional 3,600 shares in the last quarter. Capstone Asset Management Co. increased its stake in Agilent Technologies by 7.4% in the first quarter. Capstone Asset Management Co. now owns 43,126 shares of the medical research company’s stock valued at $2,280,000 after buying an additional 2,990 shares in the last quarter. Finally, Private Trust Co. NA increased its stake in Agilent Technologies by 2.1% in the first quarter. Private Trust Co. NA now owns 7,660 shares of the medical research company’s stock valued at $404,000 after buying an additional 161 shares in the last quarter.

Agilent Technologies, Inc. (A) opened at 59.33 on Friday. The firm has a market cap of $19.06 billion, a PE ratio of 33.35 and a beta of 1.30. The stock has a 50 day moving average of $60.10 and a 200-day moving average of $55.69. Agilent Technologies, Inc. has a 52 week low of $42.92 and a 52 week high of $61.84.

Agilent Technologies (NYSE:A) last posted its earnings results on Monday, May 22nd. The medical research company reported $0.58 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.48 by $0.10. Agilent Technologies had a return on equity of 16.49% and a net margin of 13.41%. The company had revenue of $1.10 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter last year, the firm earned $0.44 earnings per share. The company’s revenue was up 8.1% on a year-over-year basis. Analysts expect that Agilent Technologies, Inc. will post $2.23 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, July 26th. Investors of record on Monday, July 3rd were paid a $0.132 dividend. This represents a $0.53 dividend on an annualized basis and a yield of 0.89%. The ex-dividend date was Thursday, June 29th. Agilent Technologies’s dividend payout ratio (DPR) is presently 29.78%.

TRADEMARK VIOLATION WARNING: This report was originally posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://theolympiareport.com/2017/08/12/440-investment-group-llc-sells-700-shares-of-agilent-technologies-inc-nysea.html.

Several research firms recently issued reports on A. Jefferies Group LLC upped their price objective on shares of Agilent Technologies from $59.00 to $66.00 and gave the stock a “buy” rating in a report on Tuesday, May 23rd. BidaskClub downgraded shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Deutsche Bank AG upped their price objective on shares of Agilent Technologies from $58.00 to $62.00 and gave the stock a “buy” rating in a report on Monday, May 22nd. Wells Fargo & Company raised shares of Agilent Technologies from a “market perform” rating to an “outperform” rating and upped their price objective for the stock from $42.92 to $60.73 in a report on Wednesday, July 12th. Finally, Cowen and Company upped their price objective on shares of Agilent Technologies from $53.00 to $62.00 and gave the stock a “market perform” rating in a report on Tuesday, May 23rd. Two investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $60.12.

In other Agilent Technologies news, insider Patrick Kaltenbach sold 5,000 shares of the business’s stock in a transaction dated Thursday, July 13th. The stock was sold at an average price of $61.26, for a total transaction of $306,300.00. Following the completion of the transaction, the insider now owns 45,138 shares of the company’s stock, valued at $2,765,153.88. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Didier Hirsch sold 5,710 shares of the business’s stock in a transaction dated Thursday, June 1st. The stock was sold at an average price of $60.60, for a total value of $346,026.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 112,608 shares of company stock valued at $6,737,509.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.